The Application Value of Shexiang Baoxin Pills in the Treatment of Microcirculation Disorders after Coronary Intervention

Objective:&nbsp;To explore the practical application value of Shexiang Baoxin Pills in the treatment of microcirculation disorders after coronary intervention. Methods:&nbsp;60 patients who developed microcirculation disorders after undergoing coronary intervention in the hospital from May 2022 to May 2025 were selected and divided into a conventional group and an observation group using the random number table method, with 30 cases in each group. The conventional group only adopted the conventional treatment plan after coronary intervention, and the observation group added Shexiang Baoxin Pills on the basis of conventional treatment. The therapeutic effects of the two groups were compared. Results:&nbsp;Compared with the conventional group, the observation group had better improvement in cardiac function-related indicators, higher overall treatment effectiveness, and lower complication rate (P<0.05). Conclusion:&nbsp;In the treatment of patients with microcirculation disorders after coronary intervention, the addition of Shexiang Baoxin Pills can effectively improve the patients&rsquo; cardiac function indicators, enhance the treatment effect, and reduce complications, and has high clinical application value.